---
category: news
title: "BioXcel Therapeutics to Participate at the Canaccord Genuity 42nd Annual Growth Conference"
excerpt: "About BioXcel Therapeutics, Inc. BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology."
publishedDateTime: 2022-08-03T11:03:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/health-wiley-1993e125db1c8c28a619ece355e8c49c"
webUrl: "https://apnews.com/press-release/globe-newswire/health-wiley-1993e125db1c8c28a619ece355e8c49c"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "nb3hvlbXjYgtO2cVGMkJ+cMvaSrppX6+8PRQ8RpUJXbINTjyT7xbbzsQ8MLPWHWYEEBlN6eaQ+Opsmk0W8yCl7tWHr9ltJ3bBJ1awKO09MRNasreND1+ZuOMQIk6/ljVBLKLMJGrBmlTN5JySPOCLQGkD+2o67QKizathN7n8M8Fkrb0EKf34HD4+FJx2MpQdO7pV/S863Aa2SmaKDGCJHazoIFAQC+A16nf+u1kg9rjF0D2RLYHqDmPOstveQm5iekCw/IV9KXEl85fNUxce3spwdg5v3fYRQMZ4QICmaFh9dKMSwDoRG9T/1NhXWNAgGk736AbJZV7VD6Ip2jJAPYxhLJ0ZaSAv2oAd3Rdpm4=;1lH5NJaj1N16Ne9CgHvCyA=="
---

